These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3598154)

  • 1. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
    Schalm SW; Heytink RA; Van Buuren HR; De Man RA
    J Hepatol; 1986; 3 Suppl 2():S189-92. PubMed ID: 3598156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infection.
    Guarascio P; De Felici AP; Migliorini D; Alexander GJ; Fagan EA; Visco G
    J Hepatol; 1986; 3 Suppl 2():S149-53. PubMed ID: 3598155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
    Schalm SW; Heytink RA; van Buuren HR; de Man RA
    Lancet; 1985 Aug; 2(8451):358-60. PubMed ID: 2862516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon.
    Schalm SW
    Chemioterapia; 1988 Dec; 7 Suppl 3():26-9. PubMed ID: 3248317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant leukocyte interferon treatment of chronic hepatitis B.
    Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
    Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial.
    Guarascio P; De Felici AP; Migliorini D; Alexander GJ; Fagan EA; Visco G
    J Hepatol; 1986; 3 Suppl 2():S143-7. PubMed ID: 3298405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection.
    Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
    J Hepatol; 1986; 3 Suppl 2():S129-35. PubMed ID: 2439569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial.
    Berk L; Schalm SW; de Man RA; Heytink RA; Berthelot P; Brechot C; Boboc B; Degos F; Marcellin P; Benhamou JP
    J Hepatol; 1992 Mar; 14(2-3):305-9. PubMed ID: 1500694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
    Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
    J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of intrahepatic localization of hepatitis B core antigen in HBeAg positive patients with chronic active hepatitis B treated with interferon.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Iwai M; Kashima K; Sokawa Y
    Am J Gastroenterol; 1990 Jun; 85(6):660-4. PubMed ID: 2191593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
    Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
    J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of acyclovir in stable chronic HBsAg, HBeAg-positive carriers.
    Alexander GJ; Fagan EA; Hegarty JE; Rolando N; Guarner P; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S123-7. PubMed ID: 3298404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
    Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
    Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.